Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Degradation by the 26S proteasome of specific proteins that have been targeted by the ubiquitin pathway is the major intracellular non-lysosomal proteolytic mechanism and is involved in a broad range of processes, such as cell cycle progression, antigen presentation and control of gene expression. Recent work, reviewed here, has shown that this pathway is often the target of cancer-related deregulation and can underlie processes, such as oncogenic transformation, tumour progression, escape from immune surveillance and drug resistance.

Original publication




Journal article


Br J Cancer

Publication Date





448 - 455


Animals, Antigen Presentation, Cell Cycle Proteins, Cyclin-Dependent Kinase Inhibitor p27, Cysteine Endopeptidases, Drug Resistance, Neoplasm, Genes, p53, Humans, Microfilament Proteins, Microtubule-Associated Proteins, Multienzyme Complexes, Neoplasms, Papillomaviridae, Prognosis, Proteasome Endopeptidase Complex, Transcription Factors, Tumor Suppressor Proteins, Ubiquitins